| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/28/2026 | ±1.9% | +0.7% | over-priced |
| 05/29/2026 | ±2.2% | -0.1% | over-priced |
| 03/31/2026 | ±2.1% | +2.5% | under-priced |
| 12/02/2025 | ±1.9% | -0.7% | over-priced |
| 08/29/2025 | ±1.5% | -0.4% | over-priced |
| 05/30/2025 | ±2.1% | -0.1% | over-priced |
| 04/02/2025 | ±2.1% | +1.8% | over-priced |
| 12/04/2024 | ±1.5% | +0.6% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2027 | $1.36 | $15.2B | $1.5B |
| Q1 FY2027 | $1.19 | $14.3B | $1.3B |
| Q4 FY2026 | — | $17.7B | $1.8B |
| Q3 FY2026 | $1.28 | $15.1B | $1.4B |
TJX Companies, Inc. (The) (TJX) reports in 30 days, with the next report estimated for 11/27/2026. Across the last 8 reports, options priced an average ±1.9% earnings move while the stock actually moved 0.9% on average — the market has systematically over-priced TJX's earnings risk. Fundamentals into the print: EPS up 23.6% year-over-year, revenue up 5.4%. QuantLogix's live 5-factor engine currently reads TJX as a neutral at 52/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →